Euroopa Liit - eesti - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod vesinikkloriid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosupressandid - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Eesti - eesti - Ravimiamet

remedica limited - fingolimood - kõvakapsel - 0,5mg 98tk; 0,5mg 28tk; 0,5mg 7tk

Eesti - eesti - Ravimiamet

sandoz d.d. - meloksikaam - tablett - 7,5mg 7tk

Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - meloksikaam - tablett - 15mg 30tk; 15mg 20tk; 15mg 50tk; 15mg 100tk; 15mg 10tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - meloksikaam - tablett - 15mg 30tk; 15mg 20tk; 15mg 50tk

Eesti - eesti - Ravimiamet

ratiopharm gmbh - meloksikaam - tablett - 7,5mg 30tk; 7,5mg 50tk; 7,5mg 100tk; 7,5mg 20tk

Eesti - eesti - Ravimiamet

remedica limited - letrosool - õhukese polümeerikattega tablett - 2,5mg 50tk; 2,5mg 20tk; 2,5mg 90tk; 2,5mg 100tk; 2,5mg 10tk; 2,5mg 30tk

Eesti - eesti - Ravimiamet

remedica limited - tsinnarisiin - kõvakapsel - 75mg 50tk; 75mg 100tk

Eesti - eesti - Ravimiamet

remedica limited - sitagliptiin - õhukese polümeerikattega tablett - 50mg 56tk; 50mg 98tk; 50mg 28tk; 50mg 14tk; 50mg 30tk; 50mg 84tk

Eesti - eesti - Ravimiamet

remedica limited - sitagliptiin - õhukese polümeerikattega tablett - 25mg 56tk; 25mg 98tk; 25mg 14tk; 25mg 28tk; 25mg 84tk